Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.29
+1.024.59%
Volume:3K
Turnover:62.19K
Market Cap:4.66M
PE:- -
High:23.40
Open:23.08
Low:23.01
Close:22.27
52wk High:24.20
52wk Low:14.78
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.31
T/O Rate:1.34%
Dividend:0.77
Dividend Rate:3.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Dow Jones
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

Twist Bioscience initiated with a Sell at BWS Financial

TIPRANKS
·
Sep 09

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live
·
Sep 09

Twist Bioscience CEO, CFO to Speak at Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09

Moderately bullish activity in Moderna with shares down 1.79%

TIPRANKS
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Press Release: Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Dow Jones
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Reuters
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05